Hepatitis C drug being developed.
D002219:Carbamates / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000187:drug effects; D016174:Hepacivirus / Q000187:drug effects; D006526:Hepatitis C / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D047028:Macrocyclic Compounds; D011804:Quinolines; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
C479555:BILN 2061; D002219:Carbamates; D047028:Macrocyclic Compounds; D011804:Quinolines; D013844:Thiazoles